Jiawei Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jiawei Guo has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Siyao Yang
The Medical Record Department, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
4 shared publications- Wencui Li
Hand and Foot Surgery Department, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
3 shared publications - Daping Wang
Department of Hand and Foot Surgery, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
2 shared publications Jianquan Liu
Department of Hand and Foot Surgery, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
2 shared publicationsAozhengzheng Dong
Department of Hand and Foot Surgery, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
1 shared publication- Bin Jiang
Department of Hand and Foot Surgery, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen 518028, China
1 shared publication
Latest Publications
- Open Access
- 12 March 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Influencing factors on mechanical properties of tendon-suture system during graft preparation: a multiple linear regression analysis
Guiding the graft through the bone tunnel is a crucial step during arthroscopic ligament reconstruction, which is the preferred surgical treatment for ante
- 12 March 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Open AccessInfluencing factors on mechanical properties of tendon-suture system during graft preparation: a multiple linear regression analysis
Guiding the graft through the bone tunnel is a crucial step during arthroscopic ligament reconstruction, which is the preferred surgical treatment for ante
- Open Access
- 26 February 2026
- Published by SAGE Publications in CARTILAGE
- Vol. 17 (4) , 909-927
Chondrocyte Senescence in Osteoarthritis: Potential Targets and Pharmacological Interventions
Purpose: This review aims to elucidate the mechanisms underlying chondrocyte senescence in osteoarthritis (OA) from 4 core perspectives: extracellular inflammation, mechanical overload and stress, intracellular metabolic and signaling dysregulation, and genetics-related alterations. It further summarizes emerging therapeutic strategies targeting chondrocyte senescence to address the unmet clinical need for disease-modifying OA interventions. Findings: Accumulating evidence indicates that chondrocyte senescence drives OA progression through multiple interconnected mechanisms. These include amplification of inflammation and extracellular matrix degradation via the senescence-associated secretory phenotype (SASP), disruption of anabolic-catabolic homeostasis, dysregulation of mechanotransduction pathways under excessive mechanical load, and reshaping of intracellular metabolism and redox balance. Additional contributing mechanisms involve epigenetic dysregulation, non-coding RNA–mediated gene modulation, and impaired autophagy. Therapeutic approaches under preclinical or clinical investigation encompass senolytic and senomorphic agents, chondroprotective biological materials, genetic or RNA-based interventions, as well as strategies targeting SASP modulation and extracellular microenvironment repair. Conclusions: Chondrocyte senescence serves as a central convergent mechanism in OA pathogenesis and a promising target for disease-modifying therapies. Advances in mechanistic understanding and senescence-targeted interventions offer new avenues for translational innovation, though critical challenges related to specificity, safety, and long-term efficacy require further resolution.
- 26 February 2026
- Published by SAGE Publications in CARTILAGE
- Vol. 17 (4) , 909-927
Open AccessChondrocyte Senescence in Osteoarthritis: Potential Targets and Pharmacological Interventions
Purpose: This review aims to elucidate the mechanisms underlying chondrocyte senescence in osteoarthritis (OA) from 4 core perspectives: extracellular inflammation, mechanical overload and stress, intracellular metabolic and signaling dysregulation, and genetics-related alterations. It further summarizes emerging therapeutic strategies targeting chondrocyte senescence to address the unmet clinical need for disease-modifying OA interventions. Findings: Accumulating evidence indicates that chondrocyte senescence drives OA progression through multiple interconnected mechanisms. These include amplification of inflammation and extracellular matrix degradation via the senescence-associated secretory phenotype (SASP), disruption of anabolic-catabolic homeostasis, dysregulation of mechanotransduction pathways under excessive mechanical load, and reshaping of intracellular metabolism and redox balance. Additional contributing mechanisms involve epigenetic dysregulation, non-coding RNA–mediated gene modulation, and impaired autophagy. Therapeutic approaches under preclinical or clinical investigation encompass senolytic and senomorphic agents, chondroprotective biological materials, genetic or RNA-based interventions, as well as strategies targeting SASP modulation and extracellular microenvironment repair. Conclusions: Chondrocyte senescence serves as a central convergent mechanism in OA pathogenesis and a promising target for disease-modifying therapies. Advances in mechanistic understanding and senescence-targeted interventions offer new avenues for translational innovation, though critical challenges related to specificity, safety, and long-term efficacy require further resolution.
- Open Access
- 3 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1700784
ACADL and ADH1B signify ketone body metabolic reprogramming in osteoarthritic synovium: insights from bioinformatics and animal model studies
Introduction: Osteoarthritis (OA) is characterized by articular degeneration and chronic joint pain, partly resulting from synovial inflammation. Accumulating evidence suggests that alterations in the synovial ketone body metabolism (KBM) are closely associated with OA pathogenesis. This study aimed to investigate the metabolic changes in synovial tissues to optimize the treatment of clinical OA. Methods: Analysis of OA and normal control synovial transcriptomic datasets extracted from the Gene Expression Omnibus (GEO) identified 808 differentially expressed genes (DEGs). These DEGs were integrated with KBM-related genes from the metabolic databases, yielding 50 candidates related to OA progression. Following enrichment analysis, protein-protein interaction network construction via STRING, and machine learning with expression analysis, two genes were identified as OA biomarkers: ACADL, encoding long-chain acyl-CoA dehydrogenase and ADH1B , alcohol dehydrogenase 1 B. Results: The nomogram based on these data revealed high accuracy in the training and validation sets. Functional analysis revealed that these genes function in lipid oxidation, a process critical for synovial cell energy metabolism, as well as in the redox balance that prevents oxidative stress from worsening OA inflammation. Immune infiltration analysis revealed that their expression significantly correlated with 21 immune subtypes, including pro-inflammatory M1 macrophages and Th17 cells, which drive synovial inflammation. Molecular docking analysis identified progesterone and fomepizole as potential agents with satisfactory affinities for ACADL and ADH1B , respectively. Assessment of mouse models of OA confirmed a significant reduction in the synovium at the protein level. Discussion: ACADL and ADH1B link KBM abnormalities to immune dysregulation in the OA synovium. The nomogram enables the precise early diagnosis of OA, and progesterone and fomepizole are promising targeted therapies. These findings deepen the current understanding of OA pathogenesis and support the advancement of personalized treatments for clinical translation.
- 3 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1700784
Open AccessACADL and ADH1B signify ketone body metabolic reprogramming in osteoarthritic synovium: insights from bioinformatics and animal model studies
Introduction: Osteoarthritis (OA) is characterized by articular degeneration and chronic joint pain, partly resulting from synovial inflammation. Accumulating evidence suggests that alterations in the synovial ketone body metabolism (KBM) are closely associated with OA pathogenesis. This study aimed to investigate the metabolic changes in synovial tissues to optimize the treatment of clinical OA. Methods: Analysis of OA and normal control synovial transcriptomic datasets extracted from the Gene Expression Omnibus (GEO) identified 808 differentially expressed genes (DEGs). These DEGs were integrated with KBM-related genes from the metabolic databases, yielding 50 candidates related to OA progression. Following enrichment analysis, protein-protein interaction network construction via STRING, and machine learning with expression analysis, two genes were identified as OA biomarkers: ACADL, encoding long-chain acyl-CoA dehydrogenase and ADH1B , alcohol dehydrogenase 1 B. Results: The nomogram based on these data revealed high accuracy in the training and validation sets. Functional analysis revealed that these genes function in lipid oxidation, a process critical for synovial cell energy metabolism, as well as in the redox balance that prevents oxidative stress from worsening OA inflammation. Immune infiltration analysis revealed that their expression significantly correlated with 21 immune subtypes, including pro-inflammatory M1 macrophages and Th17 cells, which drive synovial inflammation. Molecular docking analysis identified progesterone and fomepizole as potential agents with satisfactory affinities for ACADL and ADH1B , respectively. Assessment of mouse models of OA confirmed a significant reduction in the synovium at the protein level. Discussion: ACADL and ADH1B link KBM abnormalities to immune dysregulation in the OA synovium. The nomogram enables the precise early diagnosis of OA, and progesterone and fomepizole are promising targeted therapies. These findings deepen the current understanding of OA pathogenesis and support the advancement of personalized treatments for clinical translation.
- Open Access
- 4 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 162
Sinus Tarsi Morphometry Is Correlated with Flatfoot Severity on Weight-Bearing CT
Background: Flexible flatfoot is a common musculoskeletal disorder in adolescents, which is characterized by a collapsed longitudinal arch. A common surgery like subtalar arthroereisis depends on the implant in sinus tarsi. Optimal match between them can potentially avoid postoperative pain and obtain improved prognosis. Investigations into anatomical morphology of sinus tarsi by weight-bearing CT (WBCT) may unveil the pathogenesis and facilitate the treatment of flexible flatfoot. Methods: This retrospective study included 28 control cases and 42 flatfoot cases. The sinus tarsi length (STL), the sinus tarsi width (STW), the angle between its long axis and the horizontal line (ST-H angle), the sinus tarsi angle (ST angle), and the tibial width were measured. We also calculated two ratios (STL/tibia width and STW/tibia width) to standardize individual differences. Data analysis was conducted via mean/median comparisons and subsequent linear regression. Results: The STL and the STL/tibia width were significantly greater in the flatfoot group (25.73 ± 3.50 vs. 23.09 ± 3.77 mm, p = 0.004; 0.90 ± 0.15 vs. 0.81 ± 0.14, p = 0.009). The ST angle was significantly smaller in the flatfoot group by an average of 4.63° (13.20° vs. 17.83°, p < 0.001). Linear regression revealed that female gender and smaller ST angle were significantly correlated with higher Meary angle, while smaller ST angle and greater STL/tibia width were significantly correlated with lower Pitch angle (p = 0.002, p = 0.007; p = 0.003, p = 0.004). No statistical predictive effects were observed for the other variables. Conclusions: The ST angle and STL/tibia width may serve as auxiliary parameters for implant selection in subtalar arthroereisis to improve sizing match within the sinus tarsi.
- 4 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 162
Open AccessSinus Tarsi Morphometry Is Correlated with Flatfoot Severity on Weight-Bearing CT
Background: Flexible flatfoot is a common musculoskeletal disorder in adolescents, which is characterized by a collapsed longitudinal arch. A common surgery like subtalar arthroereisis depends on the implant in sinus tarsi. Optimal match between them can potentially avoid postoperative pain and obtain improved prognosis. Investigations into anatomical morphology of sinus tarsi by weight-bearing CT (WBCT) may unveil the pathogenesis and facilitate the treatment of flexible flatfoot. Methods: This retrospective study included 28 control cases and 42 flatfoot cases. The sinus tarsi length (STL), the sinus tarsi width (STW), the angle between its long axis and the horizontal line (ST-H angle), the sinus tarsi angle (ST angle), and the tibial width were measured. We also calculated two ratios (STL/tibia width and STW/tibia width) to standardize individual differences. Data analysis was conducted via mean/median comparisons and subsequent linear regression. Results: The STL and the STL/tibia width were significantly greater in the flatfoot group (25.73 ± 3.50 vs. 23.09 ± 3.77 mm, p = 0.004; 0.90 ± 0.15 vs. 0.81 ± 0.14, p = 0.009). The ST angle was significantly smaller in the flatfoot group by an average of 4.63° (13.20° vs. 17.83°, p < 0.001). Linear regression revealed that female gender and smaller ST angle were significantly correlated with higher Meary angle, while smaller ST angle and greater STL/tibia width were significantly correlated with lower Pitch angle (p = 0.002, p = 0.007; p = 0.003, p = 0.004). No statistical predictive effects were observed for the other variables. Conclusions: The ST angle and STL/tibia width may serve as auxiliary parameters for implant selection in subtalar arthroereisis to improve sizing match within the sinus tarsi.
- Open Access
- 1 November 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (11) , 634-641
Loadless Tendon Explant Model Exhibits Spontaneous Degradative Phenotypes: An In Vitro Study of Human Tendons
Background: Although the tendon explant model has been gradually recognized for simulating tendon characteristics in vitro, there is still no consensus on a standardized culture protocol. Recently, tendon explants have been applied to senescence-related research but whether their own changes affected the credibility of the conclusions was not confirmed. Therefore, this study aimed to systematically evaluate the reliability of the loadless tendon explant model by characterizing its dynamic macroscopic morphological and molecular biological changes during culture. Methods: This study collected surgical samples from patients as loadless tendon explants for culture and conducted molecular biology and cytology tests once every 3 days within 15 days. Both their macroscopic and microscopic changes were recorded and analyzed, with each compared to the corresponding parameters at day 0. Results: Loadless tendon explants spontaneously underwent progressive disintegration, leading to the collapse of the original dense structure. Consistently, the collagen fibers also gradually became loose and fractured, contributing to a significant decrease of collage density from day 9. In addition, the senescence and apoptosis markers P21 and Caspase 3 increased over time, and there were statistically significant differences starting from day 6, respectively. The main intrinsic component, Collagen I, and the main catabolic enzyme, metalloproteinase 13 (MMP 13), could hardly be detected since day 3. During the daily evaluations from day 0 to day 4, Collagen I gradually decreased and was barely detectable by day 3, whereas MMP 13 increased on day 1 followed by a rapid decline since day 2. Conclusions: These results indicate that loadless tendon explants rapidly degrade and lose matrix integrity, with their spontaneous changes compromising the reliability of research conclusions related to senescence and apoptosis. Therefore, further optimization is still required before a well-established protocol is applied.
- 1 November 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (11) , 634-641
Open AccessLoadless Tendon Explant Model Exhibits Spontaneous Degradative Phenotypes: An In Vitro Study of Human Tendons
Background: Although the tendon explant model has been gradually recognized for simulating tendon characteristics in vitro, there is still no consensus on a standardized culture protocol. Recently, tendon explants have been applied to senescence-related research but whether their own changes affected the credibility of the conclusions was not confirmed. Therefore, this study aimed to systematically evaluate the reliability of the loadless tendon explant model by characterizing its dynamic macroscopic morphological and molecular biological changes during culture. Methods: This study collected surgical samples from patients as loadless tendon explants for culture and conducted molecular biology and cytology tests once every 3 days within 15 days. Both their macroscopic and microscopic changes were recorded and analyzed, with each compared to the corresponding parameters at day 0. Results: Loadless tendon explants spontaneously underwent progressive disintegration, leading to the collapse of the original dense structure. Consistently, the collagen fibers also gradually became loose and fractured, contributing to a significant decrease of collage density from day 9. In addition, the senescence and apoptosis markers P21 and Caspase 3 increased over time, and there were statistically significant differences starting from day 6, respectively. The main intrinsic component, Collagen I, and the main catabolic enzyme, metalloproteinase 13 (MMP 13), could hardly be detected since day 3. During the daily evaluations from day 0 to day 4, Collagen I gradually decreased and was barely detectable by day 3, whereas MMP 13 increased on day 1 followed by a rapid decline since day 2. Conclusions: These results indicate that loadless tendon explants rapidly degrade and lose matrix integrity, with their spontaneous changes compromising the reliability of research conclusions related to senescence and apoptosis. Therefore, further optimization is still required before a well-established protocol is applied.
- Open Access
- 27 March 2025
- Published by Elsevier in JPRAS Open
- Vol. 44, 379-389
Comparative study of chitosan-based liquid dressing and recombinant human epidermal growth factor on acute limb skin wound healing: A randomized controlled trial
- 27 March 2025
- Published by Elsevier in JPRAS Open
- Vol. 44, 379-389
Open AccessComparative study of chitosan-based liquid dressing and recombinant human epidermal growth factor on acute limb skin wound healing: A randomized controlled trial
- Top Cited PapersOpen Access
- 7 April 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (14)
Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression
Abnormal subchondral bone remodeling featured by overactivated osteoclastogenesis leads to articular cartilage degeneration and osteoarthritis (OA) progression, but the mechanism is unclear. We used lymphocyte cytosolic protein 1 ( Lcp1 ) knockout mice to suppress subchondral osteoclasts in a mice OA model with anterior cruciate ligament transection (ACLT), and Lcp1 −/− mice showed decreased bone remodeling in subchondral bone and retarded cartilage degeneration. For mechanisms, the activated osteoclasts in subchondral bone induced type-H vessels and elevated oxygen concentration, which ubiquitylated hypoxia-inducible factor 1 alpha subunit (HIF-1α) in chondrocytes and led to cartilage degeneration. Lcp1 knockout impeded angiogenesis, which maintained hypoxia environment in joints and delayed the OA progression. Stabilization of HIF-1α delayed cartilage degeneration, and knockdown of Hif1a abolished the protective effects of Lcp1 knockout. Last, we showed that Oroxylin A, an Lcp1- encoded protein l -plastin (LPL) inhibitor, could alleviate OA progression. In conclusion, maintaining hypoxic environment is an attractive strategy for OA treatment.
- 7 April 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (14)
Top Cited PapersOpen AccessMaintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression
Abnormal subchondral bone remodeling featured by overactivated osteoclastogenesis leads to articular cartilage degeneration and osteoarthritis (OA) progression, but the mechanism is unclear. We used lymphocyte cytosolic protein 1 ( Lcp1 ) knockout mice to suppress subchondral osteoclasts in a mice OA model with anterior cruciate ligament transection (ACLT), and Lcp1 −/− mice showed decreased bone remodeling in subchondral bone and retarded cartilage degeneration. For mechanisms, the activated osteoclasts in subchondral bone induced type-H vessels and elevated oxygen concentration, which ubiquitylated hypoxia-inducible factor 1 alpha subunit (HIF-1α) in chondrocytes and led to cartilage degeneration. Lcp1 knockout impeded angiogenesis, which maintained hypoxia environment in joints and delayed the OA progression. Stabilization of HIF-1α delayed cartilage degeneration, and knockdown of Hif1a abolished the protective effects of Lcp1 knockout. Last, we showed that Oroxylin A, an Lcp1- encoded protein l -plastin (LPL) inhibitor, could alleviate OA progression. In conclusion, maintaining hypoxic environment is an attractive strategy for OA treatment.